|
TMO
|
Thermo Fisher Scientific Inc
|
11.04%
|
US
|
NYSE
|
|
BEAM
|
Beam Therapeutics Inc.
|
9.83%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
9.55%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
8.31%
|
US
|
NASDAQ
|
|
PSTX
|
Poseida Therapeutics, Inc.
|
7.19%
|
US
|
NASDAQ
|
|
ABBV
|
AbbVie Inc.
|
5.05%
|
US
|
NYSE
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
4.59%
|
US
|
NASDAQ
|
|
DTIL
|
Precision BioSciences, Inc.
|
4.35%
|
US
|
NASDAQ
|
|
VERV
|
Verve Therapeutics, Inc.
|
4.28%
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
4.19%
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
3.72%
|
US
|
NASDAQ
|
|
NOVN
|
Novartis AG
|
3.31%
|
CH
|
SW
|
|
TSVT
|
2seventy bio, Inc.
|
3.05%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
2.93%
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
2.71%
|
US
|
NYSE
|
|
A
|
Agilent Technologies, Inc.
|
2.67%
|
US
|
NYSE
|
|
ILMN
|
Illumina, Inc.
|
1.84%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
1.38%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
1.32%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
0.72%
|
US
|
NASDAQ
|